Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Endocrine
Published in: Endocrine 1/2005

01-02-2005 | Original Articles

Serum levels of leptin, insulin, and lipids in relation to breast cancer in China

Authors: Cunzhi Han, Hong-Tao Zhang, Lili Du, Xiuying Liu, Jiexian Jing, Xianwen Zhao, Xuan Yang, Baoguo Tian

Published in: Endocrine | Issue 1/2005

Login to get access
Metadata
Title
Serum levels of leptin, insulin, and lipids in relation to breast cancer in China
Authors
Cunzhi Han
Hong-Tao Zhang
Lili Du
Xiuying Liu
Jiexian Jing
Xianwen Zhao
Xuan Yang
Baoguo Tian
Publication date
01-02-2005
Publisher
Humana Press
Published in
Endocrine / Issue 1/2005
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1385/ENDO:26:1:019

Other articles of this Issue 1/2005

Endocrine 1/2005 Go to the issue

Original Articles

Low level of cyclin D1 protein expression in thyroid microcarcinomas from an autopsy series

Original Articles

Ovulation block by Pueraria mirifica

Original Articles

Androgen-receptor coregulators mediate the suppressive effect of androgen signals on vitamin D receptor activity

Original Articles

Retinoid-related receptor (ROR) α mRNA expression is altered in the brain of male mice lacking all ligand-binding thyroid hormone receptor (TR) isoforms

Original Articles

Involvement of estrogen in the pathogenesis of cyclophosphamide-induced cystitis in rats

Original Articles

Effect of growth hromone and estrogen administration on hepatocyte alterations in old ovariectomized female wistar rats
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits